MEK Inhibition Induces Canonical WNT Signaling through YAP in <i>KRAS</i> Mutated HCT-15 Cells, and a Cancer Preventive FOXO3/FOXM1 Ratio in Combination with TNKS Inhibition
The majority of colorectal cancers are induced by subsequent mutations in <i>APC</i> and <i>KRAS</i> genes leading to aberrant activation of both canonical WNT and RAS signaling. However, due to induction of feedback rescue mechanisms some cancers do not respond well to targe...
Main Authors: | Nina Therese Solberg, Maria Melheim, Martin Frank Strand, Petter Angell Olsen, Stefan Krauss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/164 |
Similar Items
-
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy
by: Ellen Voigt, et al.
Published: (2023-09-01) -
Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells
by: Huimin Li, et al.
Published: (2023-11-01) -
MEK inhibition and immune responses in advanced melanoma
by: Reinhard Dummer, et al.
Published: (2017-08-01) -
High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis
by: Weiyingqi Cui, et al.
Published: (2023-05-01) -
Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction
by: Amanda J. Unsworth, et al.
Published: (2019-08-01)